301 related articles for article (PubMed ID: 11913973)
1. A novel in vitro assay for deubiquitination of I kappa B alpha.
Strayhorn WD; Wadzinski BE
Arch Biochem Biophys; 2002 Apr; 400(1):76-84. PubMed ID: 11913973
[TBL] [Abstract][Full Text] [Related]
2. Stimulation-dependent I kappa B alpha phosphorylation marks the NF-kappa B inhibitor for degradation via the ubiquitin-proteasome pathway.
Alkalay I; Yaron A; Hatzubai A; Orian A; Ciechanover A; Ben-Neriah Y
Proc Natl Acad Sci U S A; 1995 Nov; 92(23):10599-603. PubMed ID: 7479848
[TBL] [Abstract][Full Text] [Related]
3. Inactivation of NF-kappa B inhibitor I kappa B alpha: ubiquitin-dependent proteolysis and its degradation product.
Li CC; Dai RM; Longo DL
Biochem Biophys Res Commun; 1995 Oct; 215(1):292-301. PubMed ID: 7575604
[TBL] [Abstract][Full Text] [Related]
4. Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway.
Chen Z; Hagler J; Palombella VJ; Melandri F; Scherer D; Ballard D; Maniatis T
Genes Dev; 1995 Jul; 9(13):1586-97. PubMed ID: 7628694
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of ubiquitin-proteasome pathway-mediated I kappa B alpha degradation by a naturally occurring antibacterial peptide.
Gao Y; Lecker S; Post MJ; Hietaranta AJ; Li J; Volk R; Li M; Sato K; Saluja AK; Steer ML; Goldberg AL; Simons M
J Clin Invest; 2000 Aug; 106(3):439-48. PubMed ID: 10930447
[TBL] [Abstract][Full Text] [Related]
6. Kinetic and mechanistic studies on the hydrolysis of ubiquitin C-terminal 7-amido-4-methylcoumarin by deubiquitinating enzymes.
Dang LC; Melandri FD; Stein RL
Biochemistry; 1998 Feb; 37(7):1868-79. PubMed ID: 9485312
[TBL] [Abstract][Full Text] [Related]
7. HSP27 is a ubiquitin-binding protein involved in I-kappaBalpha proteasomal degradation.
Parcellier A; Schmitt E; Gurbuxani S; Seigneurin-Berny D; Pance A; Chantôme A; Plenchette S; Khochbin S; Solary E; Garrido C
Mol Cell Biol; 2003 Aug; 23(16):5790-802. PubMed ID: 12897149
[TBL] [Abstract][Full Text] [Related]
8. Ubiquitination and deubiquitination: targeting of proteins for degradation by the proteasome.
Wilkinson KD
Semin Cell Dev Biol; 2000 Jun; 11(3):141-8. PubMed ID: 10906270
[TBL] [Abstract][Full Text] [Related]
9. Appearance of apparently ubiquitin-conjugated I kappa B-alpha during its phosphorylation-induced degradation in intact cells.
Traenckner EB; Baeuerle PA
J Cell Sci Suppl; 1995; 19():79-84. PubMed ID: 8655651
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of NF-kappa-B cellular function via specific targeting of the I-kappa-B-ubiquitin ligase.
Yaron A; Gonen H; Alkalay I; Hatzubai A; Jung S; Beyth S; Mercurio F; Manning AM; Ciechanover A; Ben-Neriah Y
EMBO J; 1997 Nov; 16(21):6486-94. PubMed ID: 9351830
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor-alpha-inducible IkappaBalpha proteolysis mediated by cytosolic m-calpain. A mechanism parallel to the ubiquitin-proteasome pathway for nuclear factor-kappab activation.
Han Y; Weinman S; Boldogh I; Walker RK; Brasier AR
J Biol Chem; 1999 Jan; 274(2):787-94. PubMed ID: 9873017
[TBL] [Abstract][Full Text] [Related]
12. Control of IkappaBalpha proteolysis by the ubiquitin-proteasome pathway.
Tanaka K; Kawakami T; Tateishi K; Yashiroda H; Chiba T
Biochimie; 2001; 83(3-4):351-6. PubMed ID: 11295496
[TBL] [Abstract][Full Text] [Related]
13. Identification of lysine residues required for signal-induced ubiquitination and degradation of I kappa B-alpha in vivo.
Rodriguez MS; Wright J; Thompson J; Thomas D; Baleux F; Virelizier JL; Hay RT; Arenzana-Seisdedos F
Oncogene; 1996 Jun; 12(11):2425-35. PubMed ID: 8649784
[TBL] [Abstract][Full Text] [Related]
14. Proteasome regulation of Fas ligand cytotoxicity.
Matsui K; Omura S; Cui H; Schauer SL; Sonenshein GE; Ju ST
Eur J Immunol; 1997 Sep; 27(9):2269-78. PubMed ID: 9341769
[TBL] [Abstract][Full Text] [Related]
15. SCF(beta-TRCP) and phosphorylation dependent ubiquitinationof I kappa B alpha catalyzed by Ubc3 and Ubc4.
Strack P; Caligiuri M; Pelletier M; Boisclair M; Theodoras A; Beer-Romero P; Glass S; Parsons T; Copeland RA; Auger KR; Benfield P; Brizuela L; Rolfe M
Oncogene; 2000 Jul; 19(31):3529-36. PubMed ID: 10918611
[TBL] [Abstract][Full Text] [Related]
16. The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B.
Palombella VJ; Rando OJ; Goldberg AL; Maniatis T
Cell; 1994 Sep; 78(5):773-85. PubMed ID: 8087845
[TBL] [Abstract][Full Text] [Related]
17. Different mechanisms control signal-induced degradation and basal turnover of the NF-kappaB inhibitor IkappaB alpha in vivo.
Krappmann D; Wulczyn FG; Scheidereit C
EMBO J; 1996 Dec; 15(23):6716-26. PubMed ID: 8978697
[TBL] [Abstract][Full Text] [Related]
18. Signal-induced degradation of I(kappa)B(alpha): association with NF-kappaB and the PEST sequence in I(kappa)B(alpha) are not required.
Van Antwerp DJ; Verma IM
Mol Cell Biol; 1996 Nov; 16(11):6037-45. PubMed ID: 8887633
[TBL] [Abstract][Full Text] [Related]
19. The carboxy-terminus of I kappaB alpha determines susceptibility to degradation by the catalytic core of the proteasome.
Kroll M; Conconi M; Desterro MJ; Marin A; Thomas D; Friguet B; Hay RT; Virelizier JL; Arenzana-Seisdedos F; Rodriguez MS
Oncogene; 1997 Oct; 15(15):1841-50. PubMed ID: 9362451
[TBL] [Abstract][Full Text] [Related]
20. Regulatory functions of ubiquitination in the immune system.
Ben-Neriah Y
Nat Immunol; 2002 Jan; 3(1):20-6. PubMed ID: 11753406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
